RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial

Add to Collection
RCTs PK Narula, HS Rehan, KES Unni, N Gupta - Schizophrenia research, 2010 - Elsevier

Chapter : Section3
Journal Year : 2010
Cited by : 143.0

… a combination of pharmacological and behavioral therapies. … can lead to chronic diseases like diabetes, hypertension and … high-risk patients (Indian population with low baseline BMI). …..... Read More

Keywords : ["olanzapine associate weight gain", "doubleblind placebocontrolle trial", "metabolic dysfunction", "topiramate", "schizophrenia", "prevention"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0920996410000812
Google Scholar Link : https://scholar.google.com/scholar?cites=7811342463719213362&as_sdt=2005&sciodt=0,5&hl=en&num=20